1. Home
  2. BW vs NBTX Comparison

BW vs NBTX Comparison

Compare BW & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Babcock & Wilcox Enterprises Inc.

BW

Babcock & Wilcox Enterprises Inc.

HOLD

Current Price

$15.00

Market Cap

919.9M

Sector

Industrials

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$28.95

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BW
NBTX
Founded
1867
2003
Country
United States
France
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
919.9M
1.0B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BW
NBTX
Price
$15.00
$28.95
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$7.00
$26.00
AVG Volume (30 Days)
5.0M
45.0K
Earning Date
03-04-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.57
N/A
Revenue Next Year
$66.70
$11.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$2.99
52 Week High
$15.68
$41.89

Technical Indicators

Market Signals
Indicator
BW
NBTX
Relative Strength Index (RSI) 61.83 47.16
Support Level $8.03 $20.11
Resistance Level N/A $30.23
Average True Range (ATR) 1.65 2.61
MACD 0.25 -0.76
Stochastic Oscillator 82.57 1.93

Price Performance

Historical Comparison
BW
NBTX

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: